SEARCH

SEARCH BY CITATION

Keywords:

  • colorectal cancer;
  • guanylyl cyclase C;
  • GUCY2C;
  • quantitative reverse transcriptase-polymerase chain reaction;
  • staging;
  • lymph nodes;
  • metastatic disease;
  • prognostic markers;
  • predictive markers

Abstract

Although the most important prognostic and predictive marker in colorectal cancer is tumor cells in lymph nodes, ∼30% of patients who are node-negative die from occult metastases. Molecular staging employing specific markers and sensitive detection technologies has emerged as a powerful platform to assess prognosis in node-negative colon cancer. Integrating molecular staging into algorithms that individualize patient management will require validation and the definition of relationships between occult tumor cells, prognosis, and responses to chemotherapy. J. Surg. Oncol. 2012; 105:468–474. © 2012 Wiley Periodicals, Inc.